Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-05-28
DOI
10.1038/srep10357
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD24+ ovary cancer cells exhibit an invasive mesenchymal phenotype
- (2013) Kyu Sub Kang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression
- (2013) Amy P.N. Skubitz et al. GYNECOLOGIC ONCOLOGY
- Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche
- (2013) Andrea Flesken-Nikitin et al. NATURE
- Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases
- (2013) Luigi Portella et al. PLoS One
- CXC Chemokine Receptor 4 is Essential for Maintenance of Renal cell Carcinoma-Initiating Cells and Predicts Metastasis
- (2013) Maximilian Gassenmaier et al. STEM CELLS
- Small Molecule Inhibitors of CXCR4
- (2013) Bikash Debnath et al. Theranostics
- Global Proteome Analysis of the NCI-60 Cell Line Panel
- (2013) Amin Moghaddas Gholami et al. Cell Reports
- The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
- (2012) A Popple et al. BRITISH JOURNAL OF CANCER
- Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells
- (2012) M-J Jung et al. ONCOGENE
- Expression Patterns of Thymosin β4 and Cancer Stem Cell Marker CD133 in Ovarian Cancers
- (2012) Yong-Il Ji et al. PATHOLOGY & ONCOLOGY RESEARCH
- CXCR4 Expression in Prostate Cancer Progenitor Cells
- (2012) Anna Dubrovska et al. PLoS One
- Stem Cell Quiescence
- (2011) L. Li et al. CLINICAL CANCER RESEARCH
- Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
- (2011) A. D. Steg et al. CLINICAL CANCER RESEARCH
- CD133 expression associated with poor prognosis in ovarian cancer
- (2011) Jing Zhang et al. MODERN PATHOLOGY
- Concise Review: Emerging Concepts in Clinical Targeting of Cancer Stem Cells
- (2011) Zeshaan A. Rasheed et al. STEM CELLS
- Microenvironmental Regulation of Chemokine (C-X-C-Motif) Receptor 4 in Ovarian Carcinoma
- (2010) Maria V. Barbolina et al. MOLECULAR CANCER RESEARCH
- Cancer stem cells in solid tumors
- (2010) Patrick C. Hermann et al. SEMINARS IN CANCER BIOLOGY
- Therapeutic implications of cancer initiating cells
- (2009) Alessandro Scopelliti et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
- (2009) Bin-Bing S. Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
- (2009) G. Bertolini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search